As the media interview Dr. Hoffman and quote his opinions and experiences in clinical practice, we will post the outlet and the date.
Check back often to see who's asking Dr. Hoffman about Intelligent Medicine.
Multicenter Clinical Trials of LDN for MS
Researchers in the US and Italy are investigating whether the opioid receptor antagonist naltrexone, in a low dose, can relieve symptoms of multiple sclerosis.
By Ronald Hoffman, MD, and Skip Lenz, Pharm D, FASCP
![](/images/clear.gif"){kind=spacer}
